ADAR1 CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | IVVD | 7.37M | $8.11M |
 | EQ | 5.56M | $7.95M |
 | KROS | 5.39M | $85.26M |
 | IKT | 5.25M | $8.50M |
 | CTMX | 4.05M | $12.90M |
 | ROIV | 3.35M | $50.65M |
 | ABUS | 2.90M | $13.18M |
 | TSHA | 2.84M | $9.27M |
 | IMVT | 2.24M | $36.14M |
 | ETNB | 2.11M | $31.06M |
 | SVRA | 1.99M | $7.10M |
 | BIOA | 1.88M | $11.05M |
 | LXEO | 1.53M | $10.17M |
 | PRTA | 1.47M | $14.34M |
 | ABVX | 1.35M | $114.69M |
 | SEPN | 1.18M | $22.13M |
 | OABI | 1.09M | $1.75M |
 | PTGX | 989K | $65.71M |
 | REPL | 979K | $4.10M |
 | ATAI | 913K | $4.83M |
Invivyd, Inc.
IVVD
Shares Held
7.37M
Value
$8.11M
Equillium, Inc.
EQ
Shares Held
5.56M
Value
$7.95M
Keros Therapeutics, Inc.
KROS
Shares Held
5.39M
Value
$85.26M
Inhibikase Therapeutics, Inc.
IKT
Shares Held
5.25M
Value
$8.50M
CytomX Therapeutics, Inc.
CTMX
Shares Held
4.05M
Value
$12.90M
Roivant Sciences Ltd.
ROIV
Shares Held
3.35M
Value
$50.65M
Arbutus Biopharma Corporation
ABUS
Shares Held
2.90M
Value
$13.18M
Taysha Gene Therapies, Inc.
TSHA
Shares Held
2.84M
Value
$9.27M
Immunovant, Inc.
IMVT
Shares Held
2.24M
Value
$36.14M
89bio, Inc.
ETNB
Shares Held
2.11M
Value
$31.06M
Savara Inc.
SVRA
Shares Held
1.99M
Value
$7.10M
BioAge Labs, Inc.
BIOA
Shares Held
1.88M
Value
$11.05M
Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
1.53M
Value
$10.17M
Prothena Corporation plc
PRTA
Shares Held
1.47M
Value
$14.34M
Abivax S.A.
ABVX
Shares Held
1.35M
Value
$114.69M
Septerna, Inc.
SEPN
Shares Held
1.18M
Value
$22.13M
OmniAb, Inc.
OABI
Shares Held
1.09M
Value
$1.75M
Protagonist Therapeutics, Inc.
PTGX
Shares Held
989K
Value
$65.71M
Replimune Group, Inc.
REPL
Shares Held
979K
Value
$4.10M
Atai Beckley N.V
ATAI
Shares Held
913K
Value
$4.83M